08 May 2026
PBAC July 2026 Meeting Agenda Updated
The Pharmaceutical Benefits Advisory Committee (PBAC) has updated the agenda for its July 2026 meeting.
07 May 2026
PBAC releases April 2026 update on key health work
The Pharmaceutical Benefits Advisory Committee (PBAC) has released its April 2026 update, giving a summary of its recent work outside of its regular meeting schedule.
01 May 2026
PBS Website Updates and Changes – May 2026
The PBS website has been updated with new, amended and deleted items. A full list is available on the Summary of Changes page.
01 May 2026
PBS Update: Change to Glycopyrronium Cream Listing
From 1 June 2026, the PBS will update how one glycopyrronium cream item is described. This change only affects the wording, not the medicine itself.
01 May 2026
May 2026 PBAC meeting agenda now released
The agenda for the upcoming meeting of the Pharmaceutical Benefits Advisory Committee has now been published.
24 Apr 2026
Review completed on medicine stockholding rules in Australia
A 24-month review of Australia’s Minimum Stockholding Requirements for certain medicines has been finalised.
22 Apr 2026
RAAHS Prescription Rules Updated to Improve Accuracy and Avoid Delays
A recent review of Remote Area Aboriginal Health Services (RAAHS) prescriptions has found that some important details are often missing.
17 Apr 2026
Multiple Myeloma Meeting Outcome Statement Released (Feb 2026)
Multiple Myeloma Meeting Outcome Statement Released (Feb 2026)
08 Apr 2026
Lamotrigine Recommended for PBS Listing in Bipolar Treatment
The Pharmaceutical Benefits Advisory Committee has recommended adding lamotrigine to the Pharmaceutical Benefits Scheme as a restricted benefit for treating bipolar disorder.
07 Apr 2026
PBAC Update – March 2026
The latest update from the Pharmaceutical Benefits Advisory Committee following its March 2026 meeting is now available on the Pharmaceutical Benefits Scheme website.